Cost-Effectiveness Modelling of a 3-Month Tight Control Patient Management of Rheumatoid Arthritis with Certolizumab Pegol in France
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1487
https://www.valueinhealthjournal.com/article/S1098-3015(13)03392-5/fulltext
Title :
Cost-Effectiveness Modelling of a 3-Month Tight Control Patient Management of Rheumatoid Arthritis with Certolizumab Pegol in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03392-5&doi=10.1016/j.jval.2013.08.1487
First page :
A562
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1333